Market Highlights

Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.

In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth.

Increasing prevalence of cancer, rising healthcare expenditures, and developing diagnostic technologies will boost the global market during the forecast period. However, risk of infection and hematoma, lack of awareness and medical services in the developing countries will restrain the market growth during the assessment period.

Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/772

Global Carcinoembryonic Antigen Market - competitive Analysis

In 2017, Aviva Systems Corporation (ASB), a protein solutions and application provider acquired GenWay Biotech, Inc. GenWay Biotech founded in 1998 has a multi-functional technology platform specialized in proteins and antibody solutions. GenWay’s core competencies enable the company to carry out bioinformatic analyses of protein targets, produce high-quality protein antigens and ligands. The GenWay, Inc.’s CEA ELISA Kit is intended for the quantitative measurement of CEA in human serum.

Biocare Medical is a privately held company which is leading supplier of automated immunohistochemistry instrumentation, antibodies and a range of IHC products. Biocare Medical sales CARCINOEMBRYONIC ANTIGEN (CEA {P} commercially. Carcinoembryonic Antigen (CEA {M}) [COL-1] is a mouse monoclonal antibody used to qualitatively detect CEA antigen by Immuno histo chemistry in formalin-fixed paraffin-embedded (FFPE) human tissues.

Lee biosolutions is a leading manufacturer of native enzymes, proteins, antibodies recombinant proteins and biological. It manufactures CEA antigens available in lyophilised form from human metastatic liver cells. The antigens are highly pure ensuring no cross contamination with other cancer antigens.

Global Carcinoembryonic Antigen Market - Regional Analysis 

North America leads the global carcinoembryonic antigen market owing to high prevalence of colorectal cancer, increasing obese population, lifestyle changes, and increasing acceptance of new technologies. Moreover, increasing government support for research and development propels the market growth. For instance, in 2015, NIH received USD 1 billion for life science and health-related research and development programs.

Europe stands second in the global carcinoembryonic antigen market.  Factors such as advanced treatment facilities, rising skilled medical professionals and increasing prevalence of cancer drives the market within the region. In the year 2012, WHO suggested that cancer is the main cause of premature death in 28 of 53 countries in Europe.

Asia Pacific is expected to be the fastest region in the global carcinoembryonic antigen market. This can be attributed due to the increasing prevalence of gastro-intestinal cancer, rising health awareness, availability of new treatment methods, rising government support. Moreover, growing healthcare expenditure boosts the market. 

The Middle East & Africa holds the least share in the market owing to the presence of low income countries and low healthcare expenditure, especially within the African region. Within this region, the Middle East leads the market due to the presence of developed economies like United Arab Emirates, Saudi Arabia, and others. Moreover, developed healthcare infrastructure and rising number of skilled medical professionals fuels the regional market.

Market Players

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.

TABLE OF CONTENTS

1. REPORT PROLOGUE
2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

Browse Complete Report With Consider Covid19 Impact @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772

Related reports link:-

Esoteric Testing Market
Distraction Osteogenesis Devices Market
Chorea Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

https://marketreports4u.blogspot.com/